Infantile Fibrosarcoma: 2 Case Reports and Literature Review

 

 Buy Article Permissions and Reprints

Introduction

Infantile fibrosarcoma (IFS) is a rare neoplasm. Although it accounts for less than 1% of all childhood cancers, it is the most common soft tissue neoplasm in infants under the age of one [1]. We reviewed 2 recent cases from our institution.

References

• 1 Sultan I, Casanova M, Al-Jumaily U. et al . Soft tissue sarcomas in the first year of life.  Eur J Cancer. 2010;  46 2449-2456
  Google Scholar
• 2 Orbach D, Rey A, Cecchetto G. et al . Infantile fibrosarcoma: management based on the European experience.  J Clin Oncol. 2010;  28 318-323
  Google Scholar
• 3 Kurkchubasche AG, Halvorson EG, Forman EN. et al . The role of preoperative chemotherapy in the treatment of infantile fibrosarcoma.  J Pediatr Surg. 2000;  35 880-883
  Google Scholar
• 4 Corsi A, Boldrini R, Bosman C. Congenital-infantile fibrosarcoma: study of two cases and review of the literature.  Tumori. 1994;  80 392-400
  Google Scholar
• 5 Ninane J, Gosseye S, Panteon E. et al . Congenital fibrosarcoma. Preoperative chemotherapy and conservative surgery.  Cancer. 1986;  58 1400-1406
  Google Scholar
• 6 Chung EB, Enzinger FM. Infantile fibrosarcoma.  Cancer. 1976;  38 729-739
  Google Scholar
• 7 Huang SY, Wang CW, Wang CJ. et al . Combined prenatal ultrasound and magnetic resonance imaging in an extensive congenital fibrosarcoma: a case report and review of the literature.  Fetal Diagn Ther. 2005;  20 266-271
  Google Scholar
• 8 Stein-Wexler R. MR imaging of soft tissue masses in children.  Magn Reson Imaging Clin N Am. 2009;  17 489-507
  Google Scholar
• 9 Wee A, Pho RW, Ong LB. Infantile fibrosarcoma: report of cases.  Arch Pathol Lab Med. 1979;  103 236-238
  Google Scholar
• 10 McCahon E, Sorensen PH, Davis JH. et al . Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy.  Med Pediatr Oncol. 2003;  40 288-292
  Google Scholar
• 11 Knezevich SR, Garnett MJ, Pysher TJ. et al . ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma.  Cancer Res. 1998;  58 5046-5048
  Google Scholar
• 12 Whittle S, Gosain A, Brown PY. et al . Regression of a congenital mesoblastic nephroma.  Pediatr Blood Cancer. 2010;  55 364-368
  Google Scholar
• 13 Lannon CL, Sorensen PH. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages.  Semin Cancer Biol. 2005;  15 215-223
  Google Scholar
• 14 Bernstein R, Zeltzer PM, Lin F. et al . Trisomy 11 and other nonrandom trisomies in congenital fibrosarcoma.  Cancer Genet Cytogenet. 1994;  78 82-86
  Google Scholar
• 15 Gorman PA, Malone M, Pritchard J. et al . Deletion of part of the short arm of chromosome 17 in a congenital fibrosarcoma.  Cancer Genet Cytogenet. 1990;  48 193-198
  Google Scholar
• 16 Adem C, Gisselsson D, Dal Cin P. et al . ETV6 rearrangements in patients with infantile fibrosarcomas and congenital mesoblastic nephromas by fluorescence in situ hybridization.  Mod Pathol. 2001;  14 1246-1251
  Google Scholar
• 17 Kothari KC, Pandey M, Wadhwa MK. et al . Congenital infantile fibrosarcoma.  Eur J Surg Oncol. 1999;  25 94-96
  Google Scholar
• 18 Grier HE, Perez-Atayde AR, Weinstein HJ. Chemotherapy for inoperable infantile fibrosarcoma.  Cancer. 1985;  56 1507-1510
  Google Scholar
• 19 Madden NP, Spicer RD, Allibone EB. et al . Spontaneous regression of neonatal fibrosarcoma.  Br J Cancer Suppl. 1992;  18 S72-S75
  Google Scholar

Correspondence

Dr. Charles L SnyderMD 

Children's Mercy Hosptial

Department of Surgery

24th and Gillham Rd

64108 Kansas City

United States

Phone: +1 816 234 3576

Fax: +1 913 983 6371

Email: csnyder@cmh.edu